Verastem VSTM
NASDAQ VSTM
$8.20 +0.22 (+2.82%)
As of: Sep 4, 2026 · 3:59 PM EDT

Verastem (VSTM) Change in Accured Expenses (2011 - 2026)

Verastem (VSTM) posted quarterly Change in Accured Expenses of -$3.1 million for Q1 2026, down 215.05% year-over-year from $2.7 million in Q1 2025, and down 133.34% quarter-over-quarter from $9.2 million in Q4 2025.

Analysis

Verastem (VSTM) Change in Accured Expenses (2011 - 2026) Analysis & Trends

Verastem's Change in Accured Expenses history runs 16 years deep, the most recent figure standing at -$3.1 million for Q1 2026.

  • In Q1 2026, Change in Accured Expenses fell 215.05% year-over-year to -$3.1 million; the TTM figure through Mar 2026 stood at $25.1 million (up 124.0% YoY), while the FY2025 annual figure was $30.8 million, up 285.46% from the prior year.
  • Change in Accured Expenses for Q1 2026 stood at -$3.1 million, down from $9.2 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $15.0 million in Q3 2025, with the low at -$3.1 million in Q1 2026.
  • The 5-year median for Change in Accured Expenses is $1.6 million (2023), against an average of $2.2 million.
  • The sharpest annual moves came in 2022 and 2025: Change in Accured Expenses sank 292.62% in 2022, then soared 2285.16% in 2025.
  • Verastem's Change in Accured Expenses stood at $195000.0 in 2022, then surged by 724.1% to $1.6 million in 2023, then jumped by 134.41% to $3.8 million in 2024, then surged by 144.01% to $9.2 million in 2025, then tumbled by 133.34% to -$3.1 million in 2026.
  • Business Quant data shows VSTM's Change in Accured Expenses at -$3.1 million in Q1 2026, $9.2 million in Q4 2025, and $15.0 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 222.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 492.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 11.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 55.78 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 212.44 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 61.62 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 68.82 Mn
10 Verastem 814.94 Mn 678.59 Mn 36.32 Mn 3.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.20 Mn
Mar 31, 2026 -3.07 Mn
Dec 31, 2025 9.19 Mn
Sep 30, 2025 15.00 Mn
Jun 30, 2025 3.98 Mn
Mar 31, 2025 2.66 Mn
Dec 31, 2024 3.77 Mn
Sep 30, 2024 4.96 Mn
Jun 30, 2024 -182,000.00
Mar 31, 2024 -544,000.00
Dec 31, 2023 1.61 Mn
Sep 30, 2023 2.97 Mn
Jun 30, 2023 -594,000.00
Mar 31, 2023 -1.05 Mn
Dec 31, 2022 195,000.00
Sep 30, 2022 -2.87 Mn
Jun 30, 2022 4.49 Mn
Mar 31, 2022 -2.45 Mn
Dec 31, 2021 3.41 Mn
Sep 30, 2021 1.49 Mn